NEW YORK, Sept. 14, 2010 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback